These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 31882172)
1. Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease. Chiang HP; Chiu YW; Lee JJ; Hung CC; Hwang SJ; Chen HC Kidney Int; 2020 Feb; 97(2):402-413. PubMed ID: 31882172 [TBL] [Abstract][Full Text] [Related]
2. Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort. Chiang HP; Lee JJ; Chiu YW; Tsai JC; Hung CC; Hwang SJ; Chen HC Am J Hypertens; 2014 Nov; 27(11):1396-407. PubMed ID: 24727359 [TBL] [Abstract][Full Text] [Related]
3. Blood pressure control in patients with chronic kidney disease. Lee JY; Han SH Korean J Intern Med; 2021 Jul; 36(4):780-794. PubMed ID: 34153181 [TBL] [Abstract][Full Text] [Related]
4. Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study. Yamamoto T; Nakayama M; Miyazaki M; Matsushima M; Sato T; Taguma Y; Sato H; Ito S Clin Exp Nephrol; 2015 Oct; 19(5):878-86. PubMed ID: 25648765 [TBL] [Abstract][Full Text] [Related]
6. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial). Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214 [TBL] [Abstract][Full Text] [Related]
7. SPRINT and the Kidney: What Have We Learned? Wells R; Rahman M Curr Hypertens Rep; 2018 Sep; 20(11):95. PubMed ID: 30218213 [TBL] [Abstract][Full Text] [Related]
8. The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study. Okin PM; Kjeldsen SE; Devereux RB J Hypertens; 2018 Apr; 36(4):916-923. PubMed ID: 29176391 [TBL] [Abstract][Full Text] [Related]
9. Cochrane in context: pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306 [TBL] [Abstract][Full Text] [Related]
12. Timed-averaged blood pressure showed a J-curve association with stroke in elderly chronic kidney disease patients. Fu C; Zhang D; Chen H; Zhang H Ren Fail; 2022 Dec; 44(1):1677-1686. PubMed ID: 36222093 [TBL] [Abstract][Full Text] [Related]
13. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial. Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535 [TBL] [Abstract][Full Text] [Related]
14. Decreased systolic blood pressure is associated with increased risk of all-cause mortality in patients with type 2 diabetes and renal impairment: A nationwide longitudinal observational study of 27,732 patients based on the Swedish National Diabetes Register. Svensson MK; Afghahi H; Franzen S; Björk S; Gudbjörnsdottir S; Svensson AM; Eliasson B Diab Vasc Dis Res; 2017 May; 14(3):226-235. PubMed ID: 28467201 [TBL] [Abstract][Full Text] [Related]
15. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Cheng LT; Gao YL; Gu Y; Zhang L; Bi SH; Tang W; Wang T Nephrol Dial Transplant; 2008 Dec; 23(12):3895-900. PubMed ID: 18632588 [TBL] [Abstract][Full Text] [Related]
16. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT). Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
19. Blood Pressure Variability Predicts Adverse Events and Cardiovascular Outcomes in Chronic Kidney Disease: A Post-Hoc Analysis of the SPRINT Trial. Mezue K; Goyal A; Pressman GS; Horrow JC; Rangaswami J Am J Hypertens; 2017 Dec; 31(1):48-52. PubMed ID: 28985328 [TBL] [Abstract][Full Text] [Related]
20. [The results of SPRINT study from the point of nephrology]. Monhart V Vnitr Lek; 2016; 62 Suppl 6():55-57. PubMed ID: 28124932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]